Ozempic and Wegovy, which also uses semaglutide but is approved for weight loss, have also been found to have positive impacts on other comorbidities like heart health, blood pressure, and insulin
If you are taking medications, particularly anticoagulants, or have concerns about blood clotting, you should consult with a healthcare professional before starting this combination
To pull the COA covering the batch on your order, email [email protected] with your order number
Your healthcare provider is also available to answer technique questions and ensure you feel confident before your first self-injection
A: Orforglipron is a once-daily oral GLP-1 receptor agonist, while Ozempic is a once-weekly injectable semaglutide medication
Staying on a maintenance dose long-term has been associated with: Lower blood pressure Improved cholesterol levels Cardiovascular protection Freedom from food noise (constant food thoughts) For some patients at their goal weight, microdosing GLP-1 medication can be a helpful strategy for maintaining results, especially if weight loss continues at standard doses, and may also offer supportive cardiometabolic or inflammatory benefits beyond weight alone
